Home / Knowledge Centre /
Case study

Global pharma company completes seamless mass transfer of materials with Almac ONE™

In a mass transfer of materials, data alignment is crucial

As clinical trials management becomes more complex, the need for sponsors to have fast access to trustworthy data intensifies. Without it, supply chains become disjointed and the additional risk, time, and cost that manifest can quickly pose a problem to multiple stakeholders, from patients to investors.

Integration of supplies and IRT is key to securing enhanced visibility and accuracy of data; data that is critical to informing smart decision making and achieving supply chain agility throughout the study lifecycle. Yet when the physical aspects of the clinical supply chain are managed by one vendor, and the digital aspects managed by another, vital information can fall through the gaps and require substantial manual intervention (and time) to remedy. When one large pharmaceutical company needed to rapidly complete a mass transfer of clinical trial materials from one distribution facility to several others in the region, data alignment would prove more critical than ever.

Read the case study to find out more.

View Resource
Almac Logo

Almac Clinical Services

Guided by our extensive clinical supply experience and expertise, Almac Clinical Services  is  recognised as an innovative,  global solution provider within the specialised and complex market of clinical trial supply.

Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.

Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies